Home > Insider Trading > Filing (0000914190-10-000671)

Filing Details

Accession Number:: 0000914190-10-000671
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-09 17:37:05
Reporting Period:: 2010-11-05

Filing Date:: 2010-11-09
Accepted Time:: 2010-11-09 17:37:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1180145	Cardiovascular Systems Inc	CSII	Surgical & Medical Instruments & Apparatus (3841)	411698056

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1370333	M Edward Brown	651 Campus Drive St. Paul MN 55112		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-11-05	10,900	$7.12	44,168	No	4	P	Direct
Common Stock	Acquisiton	2010-11-08	3,300	$7.35	47,468	No	4	P	Direct
Common Stock	Acquisiton	2010-11-09	11,600	$8.43	59,068	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Restricted Stock Units	$0.00	3,977	3,977	Direct
Common Stock	Restricted Stock Units	$0.00	11,628	11,628	Direct
Common Stock	Restricted Stock Units	$0.00	21,739	21,739	Direct

Amount	Remaning Holdings	Nature of Ownership
3,977	3,977	Direct
11,628	11,628	Direct
21,739	21,739	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.95 to $7.399 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Comission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.3 to $7.39 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Comission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.4 to $8.5 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Comission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment, and shall be payable in shares of the Company's common stock beginning six months following the termination of each director's board membership.
Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment, and shall be payable in cash or shares of the Company's common stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in equal quarterly amounts of 5,435 on each of 9/30/2010, 12/31/2010, and 3/31/2011 and 5,434 on 6/30/2011.